Five Lupus Patients in Remission After GM Cell Therapy

Katie Tinkler spent three decades battling lupus so severe she sometimes couldn't pick up a coffee mug. Today, the 52-year-old former fitness instructor is skiing down mountains and dancing at weddings, thanks to a therapy that gave her immune system a complete reset.

Tinkler was one of five NHS patients whose severe lupus went into remission after receiving CAR T-cell therapy at University College London Hospital. The treatment, already transforming cancer care, works by removing white blood cells from patients, engineering them to hunt down the disease, and returning them to the body through a simple infusion.

The results stunned doctors. Within months, all five patients on the lower dose showed no signs of the disease that had resisted every other treatment. Their damaged kidneys began healing, their inflammation disappeared, and tests confirmed their immune systems had been reset.

Nine people with severe lupus joined the trial after exhausting every other option. Most had lupus nephritis, a dangerous complication affecting the kidneys. Six received a lower dose of the modified cells and three got a higher dose.

The five lower-dose patients have been monitored for an average of 11 months and remain in remission. The three on the higher dose are still in early stages but showing promising signs after three months.

The Ripple Effect

This breakthrough could end the need for lifelong medication that millions of lupus patients currently require. About 5 million people worldwide live with this chronic autoimmune disease, which causes the immune system to attack healthy tissues throughout the body.

The disease hits hardest between ages 15 and 45 and affects women nine times more often than men. Symptoms range from joint pain and fatigue to life-threatening organ damage in the kidneys, heart and lungs.

For Tinkler, lupus meant kidney damage, heart and lung disease, painful swollen joints, and a terrifying brush with sepsis that left her in a coma with multi-organ failure. She had to abandon her career and watched her body deteriorate despite countless treatments.

"My whole system was affected by lupus and my joints were so painful that sometimes I couldn't walk," she said. "But now I don't have these problems anymore. My life two years ago versus now, it's unrecognizable."

Professor Karl Peggs, who directed the biomedical research at UCLH, said larger studies are needed but the results suggest something remarkable. "The possibility that CAR T-cell therapy could deliver an immune reset and potentially free patients from the cycle of chronic autoimmune disease marks a remarkable step forward," he said.

The therapy requires just one treatment instead of daily medications for life. Patients receive the infusion and their reprogrammed cells continue working to keep their immune system balanced.

A cure for lupus may finally be within reach.